128940.KS
Hanmi Pharm. Co., Ltd.
KSEKRWEQUITY
Healthcare
DELAYED
Last price
415,500.00
▲ 16,500.00 (4.14%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
390,000.00
Prev close
399,000.00
Day high
428,000.00
Day low
380,500.00
Volume
124.03K
Market cap
$5.27T
P/E (TTM)
—
52W range
286,000.00 – 647,000.00
Day trading desk
Gap from prior close
-2.26%
Prior close 399,000.00
VWAP
409,480.10
+1.47% from price
Relative volume
0.97×
Normal
Session range
12.48%
380,500.00 – 428,000.00
Position in range
74%
Near session high
ATR (14D)
21,910.71
5.27% of price
Prior day high
406,500.00
PDH
Prior day low
384,000.00
PDL
Bid / ask spread
—
Quote not published
Session volume
123.89K
Avg 128.38K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+4.27%
+5.6%
1M
+12.60%
+8.9%
3M
+0.24%
-2.9%
6M
-32.33%
-43.4%
YTD
-8.08%
-20.4%
1Y
+46.56%
+26.6%
3Y
+54.96%
-19.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 128940.KS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
6.36M
Total on file
Fundamentals
Market cap$5.27T
Enterprise value$5.47T
Revenue (TTM)$1.66T
Gross profit$986.57B
EBITDA$375.90B
Net income$217.04B
EPS (TTM)—
Free cash flow$48.71B
Total cash$409.31B
Total debt$417.86B
Book value / share—
Shares outstanding12.68M
Float6.27M
Short % of float—
Dividend yield0.48%
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue3.30
EV / EBITDA14.54
Gross margin59.59%
Operating margin26.43%
Profit margin13.11%
Return on equity16.36%
Return on assets8.04%
Debt / equity26.30
Current ratio1.82
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.55T | $1.50T | $1.49T | $1.33T | +3.5% |
| Operating revenue | $1.55T | $1.50T | $1.49T | $1.33T | +3.5% |
| Cost of revenue | $663.12B | $678.46B | $661.64B | $612.99B | -2.3% |
| Gross profit | $884.41B | $817.04B | $829.25B | $718.55B | +8.2% |
| Research & development | $195.83B | $178.89B | $181.77B | $154.32B | +9.5% |
| Selling, general & admin | $225.89B | $233.69B | $248.24B | $233.63B | -3.3% |
| Total operating expense | $626.61B | $600.85B | $604.36B | $560.46B | +4.3% |
| Operating income | $257.80B | $216.19B | $224.88B | $158.09B | +19.2% |
| Net interest income | -$9.72B | -$18.88B | -$24.87B | -$15.58B | +48.5% |
| Pre-tax income | $213.48B | $171.25B | $193.97B | $121.01B | +24.7% |
| Tax provision | $26.34B | $30.82B | $28.60B | $19.45B | -14.5% |
| Net income | $169.55B | $121.32B | $146.23B | $82.79B | +39.8% |
| Net income to common | $169.55B | $121.32B | $146.23B | $82.79B | +39.8% |
| Basic EPS | 13,372.00 | 9,567.00 | 11,522.00 | 6,389.22 | +39.8% |
| Diluted EPS | 13,362.00 | 9,567.00 | 11,522.00 | 6,389.22 | +39.7% |
| EBIT | $230.46B | $195.63B | $222.48B | $143.66B | +17.8% |
| EBITDA | $329.27B | $292.96B | $320.93B | $240.50B | +12.4% |
| Basic shares | 12.68M | 12.68M | 12.69M | 12.96M | -0.0% |
| Diluted shares | 12.69M | 12.68M | 12.69M | 12.96M | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $108.27B | $192.28B | $54.98B | $147.33B | -43.7% |
| Cash & short-term investments | $201.32B | $193.20B | $255.18B | $236.74B | +4.2% |
| Accounts receivable | $337.29B | $238.25B | $168.14B | $178.36B | +41.6% |
| Inventory | $338.53B | $300.93B | $288.81B | $266.19B | +12.5% |
| Total current assets | $893.95B | $746.31B | $730.62B | $694.16B | +19.8% |
| Property, plant & equipment | $786.29B | $822.50B | $860.24B | $917.98B | -4.4% |
| Goodwill & intangibles | $113.28B | $94.14B | $81.05B | $84.59B | +20.3% |
| Total assets | $2.14T | $2.02T | $1.90T | $1.92T | +5.8% |
| Total current liabilities | $605.20B | $682.76B | $704.76B | $676.75B | -11.4% |
| Current debt | $333.05B | $401.84B | $481.45B | $449.46B | -17.1% |
| Long-term debt | $91.81B | $85.86B | $82.03B | $217.33B | +6.9% |
| Total debt | $434.21B | $496.69B | $572.87B | $678.32B | -12.6% |
| Total liabilities | $714.74B | $780.09B | $798.46B | $915.36B | -8.4% |
| Retained earnings | $836.49B | $680.89B | $581.98B | $452.30B | +22.9% |
| Shareholder equity | $1.25T | $1.08T | $955.44B | $871.87B | +15.2% |
| Working capital | $288.75B | $63.55B | $25.86B | $17.41B | +354.4% |
| Net tangible assets | $1.14T | $990.76B | $874.40B | $787.28B | +14.7% |
| Shares issued | 12.68M | 12.81M | 12.56M | 12.58M | -1.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $187.14B | $140.43B | $165.37B | $101.56B | — | +33.3% |
| Depreciation & amortisation | $98.81B | $97.33B | $98.45B | $96.84B | — | +1.5% |
| Change in working capital | -$150.07B | -$90.26B | -$57.40B | -$73.69B | — | -66.3% |
| Operating cash flow | $173.07B | $193.49B | $216.54B | $162.27B | — | -10.6% |
| Capital expenditure | -$76.55B | -$62.55B | -$43.74B | -$49.59B | — | -22.4% |
| Investing cash flow | -$159.46B | $24.85B | -$183.47B | -$181.41B | — | -741.6% |
| Share buybacks | — | -$3.28B | -$3.07B | -$3.83B | -$4.87B | — |
| Dividends paid | -$30.86B | -$12.56B | -$18.00B | -$5.99B | — | -145.8% |
| Financing cash flow | -$97.19B | -$93.77B | -$126.79B | -$36.87B | — | -3.7% |
| Free cash flow | $96.53B | $130.93B | $172.80B | $112.68B | — | -26.3% |
| End cash position | $108.27B | $192.28B | $54.98B | $147.33B | — | -43.7% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $392.93B | $432.96B | $362.35B | $361.28B | $390.95B | — | -9.2% |
| Operating revenue | $392.93B | $432.96B | $362.35B | $361.28B | $390.95B | — | -9.2% |
| Cost of revenue | $175.64B | $172.48B | $156.75B | $156.54B | $177.35B | — | +1.8% |
| Gross profit | $217.29B | $260.48B | $205.59B | $204.74B | $213.59B | — | -16.6% |
| Research & development | $57.12B | $51.66B | $54.65B | $44.05B | $45.48B | — | +10.6% |
| Selling, general & admin | $52.59B | $64.30B | $54.44B | $53.10B | $54.06B | — | -18.2% |
| Total operating expense | $163.64B | $177.20B | $150.53B | — | $154.57B | $154.78B | -7.7% |
| Operating income | $53.65B | $83.27B | $55.07B | $204.74B | $59.02B | — | -35.6% |
| Net interest income | -$783.67M | -$1.14B | -$2.27B | -$2.86B | -$3.49B | — | +31.3% |
| Pre-tax income | $55.38B | $58.49B | $52.26B | $49.55B | $53.18B | — | -5.3% |
| Tax provision | $4.30B | $4.43B | $6.85B | $6.54B | $8.52B | — | -3.1% |
| Net income | $45.49B | $48.12B | $40.13B | $38.70B | $42.61B | — | -5.5% |
| Net income to common | $45.49B | $48.12B | $40.13B | $38.70B | $42.61B | — | -5.5% |
| Basic EPS | 3,586.00 | — | 3,165.00 | 3,052.00 | 3,360.00 | — | — |
| Diluted EPS | 3,586.00 | — | 3,165.00 | 3,052.35 | 3,360.00 | — | — |
| EBIT | $58.79B | $62.14B | $56.20B | $204.74B | $58.28B | — | -5.4% |
| EBITDA | $83.49B | $87.43B | $80.77B | $204.74B | $82.76B | — | -4.5% |
| Basic shares | 12.69M | — | 12.68M | — | 12.68M | — | — |
| Diluted shares | 12.69M | — | 12.68M | 12.68M | 12.68M | — | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $140.40B | $108.27B | $84.40B | — | $84.36B | $192.28B | +29.7% |
| Cash & short-term investments | $298.38B | $201.32B | $225.32B | $188.04B | $218.53B | — | +48.2% |
| Accounts receivable | $295.04B | $337.29B | $253.61B | — | $195.16B | $238.25B | -12.5% |
| Inventory | $366.77B | $338.53B | $318.76B | — | $285.63B | $300.93B | +8.3% |
| Total current assets | $982.80B | $893.95B | $820.24B | $736.75B | $720.41B | — | +9.9% |
| Property, plant & equipment | $789.56B | $786.29B | $790.70B | — | $805.64B | $822.50B | +0.4% |
| Goodwill & intangibles | $119.84B | $113.28B | $104.01B | — | $100.26B | $94.14B | +5.8% |
| Total assets | $2.23T | $2.14T | $2.04T | $1.96T | $1.98T | — | +4.1% |
| Total current liabilities | $637.53B | $605.20B | $585.65B | $596.30B | $622.87B | — | +5.3% |
| Current debt | $317.60B | $333.05B | $333.05B | — | $383.67B | $401.84B | -4.6% |
| Long-term debt | $91.38B | $91.81B | $92.70B | $74.59B | $80.22B | — | -0.5% |
| Total debt | $418.36B | $434.21B | $435.72B | — | $472.39B | $496.69B | -3.6% |
| Total liabilities | $747.44B | $714.74B | $694.79B | $683.35B | $714.64B | — | +4.6% |
| Retained earnings | $856.60B | $836.49B | $789.65B | — | $710.81B | $680.89B | +2.4% |
| Shareholder equity | $1.30T | $1.25T | $1.18T | $1.13T | $1.11T | — | +4.0% |
| Working capital | $345.27B | $288.75B | $234.58B | $140.45B | $97.54B | — | +19.6% |
| Net tangible assets | $1.18T | $1.14T | $1.08T | $1.03T | $1.01T | — | +3.8% |
| Shares issued | 12.81M | 12.68M | 12.81M | 12.81M | 12.81M | — | +1.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $51.08B | $54.05B | $45.42B | $43.01B | $44.65B | — | -5.5% |
| Depreciation & amortisation | $24.71B | $25.29B | $24.57B | — | $24.49B | $24.41B | -2.3% |
| Change in working capital | $42.84B | -$100.02B | -$30.33B | — | $19.17B | -$37.94B | +142.8% |
| Operating cash flow | $111.64B | $14.51B | $42.02B | $37.20B | $79.35B | — | +669.5% |
| Capital expenditure | -$18.64B | -$27.72B | -$15.95B | -$19.70B | -$13.18B | — | +32.8% |
| Investing cash flow | -$67.91B | $6.64B | -$35.61B | — | -$144.97B | $125.38B | -1,123.4% |
| Share buybacks | — | — | — | — | — | $0 | — |
| Dividends paid | — | -$105.00M | $3.04B | -$17.30B | -$16.50B | -$105.95M | — |
| Financing cash flow | -$17.20B | -$1.91B | -$1.49B | — | -$41.10B | -$7.22B | -802.8% |
| Free cash flow | $93.00B | -$13.21B | $26.07B | — | $66.17B | -$6.77B | +804.0% |
| End cash position | $140.40B | $108.27B | $84.40B | $78.54B | $84.36B | — | +29.7% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $375.54B | +3.6% |
| Next quarter | — | — | $441.33B | +1.9% |
| Current year | 16,039.74 | 8 | $1.68T | +8.6% |
| Next year | 16,912.65 | 11 | $1.76T | +31.1% |
Analyst targets & ownership
Mean target$595,000.00
High target$700,000.00
Low target$500,000.00
Implied upside43.20%
Analyst count12
ConsensusSTRONG BUY
Strong buy / Buy6 / 6
Hold0
Sell / Strong sell0 / 0
Held by insiders50.09%
Held by institutions22.18%
Institutions holding109
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
400,100.00
+3.85% from price
SMA 20
380,975.00
+9.06% from price
SMA 50
394,440.00
+5.34% from price
SMA 100
437,765.00
-5.09% from price
SMA 200
460,282.50
-9.73% from price
EMA 12
394,552.43
+5.31% from price
EMA 26
391,123.96
+6.23% from price
EMA 50
401,611.09
+3.46% from price
RSI (14)
57.7
Neutral
MACD (12,26,9)
3,428.47
Hist 4,556.96
ATR (14)
21,910.71
5.27% of price
Realised vol 30D
72.7%
Annualised
Bollinger upper
438,557.53
20, 2σ
Bollinger lower
323,392.47
20, 2σ
50 / 200 cross
Death
394,440.00 vs 460,282.50
Trend bias
Below 200
-9.73%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.02
Less volatile than market
Correlation to SPY
0.00
Largely independent
Realised vol 30D
72.7%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-50.2%
Peak to trough
Max drawdown 5Y
-50.2%
Peak to trough
ATR 14
21,910.71
5.27% of price
Beta (reported)
—
5Y monthly, from filing
Dividends & splits
Forward rate$2,000.00 / yr
Forward yield0.48%
5-year avg yield0.23%
Payout ratio11.70%
Ex-dividend dateMar 30, 2026
Next pay date—
Last split1.02:1
Split dateDec 27, 2023
Headlines
Kane voted German footballer of the year
AFP · 10m ago
Asphalt Expert Robert Stewart Explains Asphalt Driveway Installation Preparation in HelloNation
PR Newswire · 12m ago
Is GE Vernova Under $1,000 a Bargain or a Trap? Here's the Honest Answer.
Motley Fool · 13m ago
The Idiot’s Guide to Stocks
24/7 Wall St. · 16m ago
Exclusive: Anthropic's $2 Trillion Valuation Faces a Reality Check—SPCX Offers a Warning, Wall Street Veteran Says
Benzinga Private Markets · 16m ago
Trump made a multimillion-dollar bond bet — and Fed Chair Kevin Warsh could shape the outcome. What investors can learn
Moneywise · 16m ago
DREAMO and DREAMOSIS Bring the Collectible Character Into a New Physical-Digital World
PR Newswire · 16m ago
Bio Ionic Partners with Ulta Beauty on Limited Edition Jade Dream Collection
PR Newswire · 16m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.